<?xml version="1.0" encoding="UTF-8"?>
<p id="p0075">The results of virtual screening of FDA approved drugs against COVID-Mpro is presented in 
 <xref rid="ec0005" ref-type="supplementary-material">Supplementary Table 1</xref>. The presented parameters include the docking scores, ligand efficiency, lipophilic and hydrogen bonding interactions. The top 20 hits showing the highest docking score are provided in 
 <xref rid="t0010" ref-type="table">Table 2</xref>. The data were presented as a relative value to curcumin (a previously approved SARS Mpro inhibitor). Curcumin docking score was ranked at the 334 position, implying the presence of wide range of expected more powerful binding drugs. Within the top 20 drugs there was 2 antivirals, 2 antituberculous agents, 2 vitamins, 1 anticancer and other miscellaneous systemically acting drugs.
</p>
